Untimely Triggering of the Fusion Mechanism Used by Viruses for Entry: A New Antiviral Approach Using Engineered Microparticles

Anne Moscona of Weill-Cornell Medical College will investigate a new approach to treating respiratory viral disease by using artificial cell-like structures to present molecules that would attract the virus and activate the fusion mechanism it uses to enter cells. By triggering this mechanism prematurely, viruses can't enter target cells and cause infection.